Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 3/20 | 0.85 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 4/20 | 0.61 |
| ▸ | CA2 | P00918 | 4/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | MMP13 | P45452 | 1/20 | 0.56 |
| ▸ | F10 | P00742 | 1/20 | 0.54 |
| ▸ | CRHBP | P24387 | 1/20 | 0.54 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL837307 | 0.92 | PLK1 (1.00) | PLK1SMN1; SMN2HPGDTSHRHTT | |
| Hydrochloric Acid SCHEMBL11037223 | 0.90 | PLK1 (0.96) | PLK1SMN1; SMN2HPGDTSHRHTT | |
| SCHEMBL23484773 | 0.87 | PLK1 (0.89) | PLK1SMN1; SMN2HPGDTSHRHTT | |
| SCHEMBL14722006 | 0.87 | PLK1 (0.89) | PLK1SMN1; SMN2HPGDTSHRHTT | |
| SCHEMBL8717056 | 0.82 | PLK1 (0.80) | PLK1SMN1; SMN2HTTCA1CA2 | |
| SCHEMBL5582971 | 0.80 | PLK1 (0.74) | PLK1SMN1; SMN2HPGDTSHRHTT | |
| SCHEMBL4754917 | 0.78 | ALDH1A1 (0.78) | PLK1SMN1; SMN2HTTCA1CA2 | |
| SCHEMBL11705060 | 0.78 | MAPT (0.79) | PLK1SMN1; SMN2HPGDCA1CA2 | |
| SCHEMBL2645679 | 0.78 | HPGD (0.76) | PLK1SMN1; SMN2HPGDTSHRHTT | |
| SCHEMBL13184545 | 0.78 | HPGD (1.00) | PLK1SMN1; SMN2HPGDTSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2383264-B1 | EPOXY COMPOUND PRODUCTION METHOD | SHOWA DENKO KK (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-8536352-B2 | Method of producing epoxy compounds | SHOWA DENKO K.K. (JP) | 2013-09-17 | — | — | US | disclosed |
| US-8466303-B2 | Process for production of epoxy compound | SHOWA DENKO K.K. (JP) | 2013-06-18 | — | — | US | disclosed |
| EP-2383264-A1 | EPOXY COMPOUND PRODUCTION METHOD | Showa Denko K.K. (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-20110263882-A1 | METHOD OF PRODUCING EPOXY COMPOUNDS | SHOWA DENKO K.K. (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20110009652-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | SHOWA DENKO KK (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2261219-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | Showa Denko K.K. (JP) | 2010-12-15 | — | — | EP | disclosed |
| EP-0537786-B1 | Preparation of N-acylaminomethylphosphonic acid | SHOWA DENKO KK (JP) | 1998-01-21 | — | — | EP | disclosed |
| US-5453537-A | Method for preparing an N-phosphonomethylglycine | SHOWA DENKO K.K. (JP) | 1995-09-26 | — | — | US | disclosed |
| US-5324855-A | Mixing an N-methylolamide with phosphorus trihalide in aprotic solvent, in presence of water, heating, then adding more water, efficiency, simplification | SHOWA DENKO K.K. (JP) | 1994-06-28 | — | — | US | disclosed |
| EP-0537786-A1 | Preparation of N-acylaminomethylphosphonic acid | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1993-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263882-A1 | METHOD OF PRODUCING EPOXY COMPOUNDS | AOX1, NOX4, AOC2 | PLK1 3279/4885SMN1; SMN2 4475/4885HPGD 109/4885 |
| US-20110009652-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | DUOX2, EPX, DUOX1 | PLK1 2866/4885SMN1; SMN2 3907/4885HPGD 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.